56 Results

People

  1. Chandarlapaty
    Chandarlapaty
  2. Rosen
    Rosen
  3. Rodrik - Outmezguine
    Rodrik - Outmezguine
  4. Baselga
    Baselga
  5. King
    King
  6. Sakr
    Sakr
  7. Hudis
    Hudis
  8. De Stanchina
    De Stanchina
  9. Modi
    Modi
  10. Norton
    Norton

Groups

  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (56)
  2. Breast Medicine Service (56)
  3. Department of Medicine (56)
  4. GSK Faculty (56)
  5. Human Oncology and Pathogenesis Program (56)
  6. Molecular Pharmacology and Chemistry Program Faculty (56)
  7. Sloan Kettering Institute Faculty (56)
  8. Solid Tumor Oncology Division (56)
  9. Sloan Kettering Institute Postdocs (25)
  10. Surgery (17)
  1. "Neal Rosen"
  2. "Sarat Chandarlapaty"
Formats
  1. Meeting Abstract (30)
  2. Journal Article (26)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (56)
  2. Breast Medicine Service (56)
  3. Department of Medicine (56)
  4. GSK Faculty (56)
  5. Human Oncology and Pathogenesis Program (56)
  6. Molecular Pharmacology and Chemistry Program Faculty (56)

More Groups

People
  1. Neal Rosen (56)
  2. Sarat Chandarlapaty (56)
  3. Vanessa Rodrik - Outmezguine (14)
  4. Jose Baselga (13)
  5. Rita Sakr (13)
  6. Tari King (13)

More People

Years
  1. 2022 (3)
  2. 2021 (3)
  3. 2020 (1)
  4. 2018 (2)
  5. 2017 (1)
  6. 2016 (1)

More Years

Publications
  1. Cancer Research (23)
  2. Clinical Cancer Research (6)
  3. Cancer Cell (5)
  4. Cancer Discovery (4)
  5. Journal of Clinical Oncology (4)
  6. Oncogene (3)

More Publications

Publishers
  1. American Association for Cancer Research (33)
  2. Cell Press (6)
  3. Nature Publishing Group (5)
  4. American Society of Clinical Oncology (4)
  5. Elsevier Inc. (3)
  6. American Association for the Advancement of Science (1)

More Publishers

Results (56)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Estrogen receptor expression and ER dependent breast tumor growth are dependent on translation initiation factor EIF4A
    Meeting Abstract

    Boyer, J. A.; Dorso, M. A.; Amor, C.; Reiter, J.; Xu, J.; de Stanchina, E.; Wendel, H. G.; Chandarlapaty, S.; Rosen, N.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Reversibility of tumor adaptations to PI3K inhibition decreases as a function of time
    Meeting Abstract

    Mukherjee, R.; de Stanchina, E.; Chandarlapaty, S.; Rosen, N.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • INK4 tumor suppressor proteins mediate resistance to CDK4/6 kinase inhibitors
    Journal Article

    Li, Q.; Jiang, B.; Guo, J.; Shao, H.; Del Priore, I. S.; Chang, Q.; Kudo, R.; Li, Z.; Razavi, P.; Liu, B.; more...
    Cancer Discovery (2022)

    Fulltext@MSK | Save
  • HER2 + breast cancers evade anti-HER2 therapy via a switch in driver pathway
    Journal Article

    Smith, A. E.; Ferraro, E.; Safonov, A.; Morales, C. B.; Lahuerta, E. J. A.; Li, Q.; Kulick, A.; Ross, D.; Solit, D. B.; de Stanchina, E.; more...
    Nature Communications (2021)

    Fulltext@MSK | Save
  • A phase I study of alpelisib in combination with trastuzumab and LJM716 in patients with PIK3CA-mutated HER2-positive metastatic breast cancer
    Journal Article

    Jhaveri, K.; Drago, J. Z.; Shah, P. D.; Wang, R.; Pareja, F.; Ratzon, F.; Iasonos, A.; Patil, S.; Rosen, N.; Fornier, M. N.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Regulation of PTEN translation by PI3K signaling maintains pathway homeostasis
    Journal Article

    Mukherjee, R.; Vanaja, K. G.; Boyer, J. A.; Gadal, S.; Solomon, H.; Chandarlapaty, S.; Levchenko, A.; Rosen, N.
    Molecular Cell (2021)

    Fulltext@MSK | Save
  • Regulation of PTEN translation by PI3K signaling maintains pathway homeostasis
    Meeting Abstract

    Mukherjee, R.; Vanaja, K. G.; Boyer, J. A.; Qiu, J.; Chen, X.; de Stanchina, E.; Chandarlapaty, S.; Levchenko, A.; Rosen, N.
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Loss of the FAT1 tumor suppressor promotes resistance to CDK4/6 inhibitors via the Hippo pathway
    Journal Article

    Li, Z.; Razavi, P.; Li, Q.; Toy, W.; Liu, B.; Ping, C.; Hsieh, W.; Sanchez-Vega, F.; Brown, D. N.; Da Cruz Paula, A. F.; more...
    Cancer Cell (2018)

    Fulltext@MSK | Save
  • Accelerating discovery of functional mutant alleles in cancer
    Journal Article

    Chang, M. T.; Shrestha Bhattarai, T.; Schram, A. M.; Bielski, C. M.; Donoghue, M. T. A.; Jonsson, P.; Chakravarty, D.; Phillips, S.; Kandoth, C.; Penson, A.; more...
    Cancer Discovery (2018)

    Fulltext@MSK | Save
  • Acquired CDK6 amplification promotes breast cancer resistance to CDK4/6 inhibitors and loss of ER signaling and dependence
    Journal Article

    Yang, C.; Li, Z.; Bhatt, T.; Dickler, M.; Giri, D.; Scaltriti, M.; Baselga, J.; Rosen, N.; Chandarlapaty, S.
    Oncogene (2017)

    Fulltext@MSK | Save